Paragon 28 Inc (FNA) Return on Assets ROA from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket
 


Paragon 28 inc   (NYSE: FNA)


Paragon 28 Inc 's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Paragon 28 Inc 's ROA in the fourth quarter of 2024?
Paragon 28 Inc recorded a cumulative net loss of $-55 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on assets (ROA) of -17.8%.

However, within the Healthcare sector 397 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from 3766 to 4142.

What is ROA?



Return On Assets (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change -12.61 % 4.83 % 4.49 % 3.78 % 30.92 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -55 -66 -65 -64 -58
Return On Assets (TTM) -17.8 % -20.75 % -20.6 % -20.65 % -18.7 %
FNA's Total Ranking # 4142 # 3766 # 3776 # 3835 # 4354
Total Assets (TTM) in million 291 302 310 324 333
Seq. Total Assets Change -3.74 % -2.72 % -4.29 % -2.5 % 15.47 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 119
Sector # 398
Overall # 4079

Return On Assets Statistics
High Average Low
-8.38 %
-20.44 %
-25.58 %
(Sep 30 2022)   (Sep 30 2023)



  News about Paragon 28 inc Return on Assets ROA

Paragon 28 Faces Legal Scrutiny Kaskela Law LLC Investigates Proposed Stockholder Buyout

Paragon 28, Inc. (NYSE: FNA), a company specializing in innovative surgical solutions for foot and ankle care, is under the spotlight as Kaskela Law LLC has announced an investigation into its proposed stockholder buyout. This development comes at a time when the company s stock is valued at approximately $13.015, with an estimated 82.79 million shares outstanding. As investors contemplate the implications of this investigation, the landscape of Paragon 28 is unfolding with both potential opportunities and challenges.The proposed stockholder buyout has raised eyebrows among investors and industry observers alike. Kaskela Law LLC, known for its advocacy on behalf of shareholders, has initiated an inquiry to explore whether the company’s leadership is acting in the best interest of its stockholders. The firm encourages affected investors to contact them for further insights suggesting that there may be significant underlying concerns related to the buyout.

In the realm of securities litigation, Rosen Law Firm, a globally recognized advocate for investor rights, ...

Investors Urged to Secure Counsel as Rosen Law Firm Leads Securities Class Action Against Paragon 28, Inc. In the realm of securities litigation, Rosen Law Firm, a globally recognized advocate for investor rights, has once again taken a proactive stance by spearheading a securities class action lawsuit against Paragon 28, Inc. (NYSE: FNA). Esteemed for its commitment to safeguarding investors, Rosen Law Firm now encourages shareholders of Paragon 28 to engage competent legal counsel ahead of a pivotal deadline November 29, 2024.The lawsuit, filed in the interest of purchasers of Paragon 28 s common stock as well as those who were involved in trading Paragon 28 call options or selling put options during the specified Class Period from May 5, 2023, to August 8, 2024, alleges securities law violations that have potentially impacted numerous investors. The legal battle at hand seeks to address these concerns, with a focus on providing equitable recourse for the financial detriment sustained by shareholders.

Potential Legal Recourse for Paragon 28 Investors Evaluating Your Rights Following Substantial Financial Losses

In the ever-evolving landscape of the stock market, investors often find themselves navigating a tumultuous terrain filled with risks and uncertainties. Paragon 28, Inc. (NYSE: FNA), a company specializing in innovative solutions for the orthopedic industry, has recently emerged as a focal point for scrutiny due to significant fluctuations in its stock performance. This has led to a growing chorus of concerns from investors who have experienced considerable financial losses. In light of these developments, Bernstein Liebhard LLP has stepped forward to offer legal assistance for affected investors, underscoring the importance of understanding one s rights in such turbulent times.The recent waves of financial turbulence surrounding Paragon 28 have raised red flags for many investors. The company s stock has faced notable volatility, prompting investors to reassess the stability and sustainability of their investments. As financial markets continue to grapple with uncertainty, the plight of Paragon 28 investors becomes increasingly urgent, particularly for those who have encountered substantial losses. Bernstein Liebhard LLP, a law firm specializing in the representation of investors in securities fraud cases, has launched an initiative to provide guidance and legal recourse for individuals impacted by dwindling investment values in Paragon 28. The firm encourages affected investors to come forward to discuss their rights and potential actions they can pursue. The acknowledgment of these rights is critical to navigating the complexities of securities law, especially for those considering whether to pursue claims for damages due to alleged company misconduct or misinformation.




Financial Statements
Paragon 28 Inc 's Assets $ 291 million FNA's Balance sheet
Paragon 28 Inc 's Income $ -11 million Quarterly FNA's Income Statement
FNA's Income by Division See FNA's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021

FY
Y / Y Total Assets Change -12.61 % 30.92 % 8.34 % - -
Total Assets in million 291 333 254 235 0
Y / Y Net Income Change - - - - -
Net Income in million -55 -58 -67 -14 0
Annual Return On Assets -18.79 % -17.29 % -26.49 % -5.84 % -




More Return On Assets Ratios
FNA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FNA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FNA's Competitors
Subscribers only: Roa for Paragon 28 Inc 's Suppliers
Subscribers only: Return On Assets for FNA's Customers

You may also want to know
FNA's Roi FNA's Inventory Turnover Ratio FNA's Growth Rates FNA's Dividend Comparisons
FNA's Profitability Ratios FNA's Asset Turnover Ratio FNA's Dividend Growth
FNA's Roe FNA's Valuation Ratios FNA's Financial Strength Ratios FNA's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2024, within Healthcare Sector ROA


Date modified: 2026-09-26T09:12:34+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.